NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
BIIB — BIOGEN INC.
Phase 3
• Primary Membranous Nephropathy
TL;DR
Locations updated — PHASE3
What changed
Recent events (last 90 days)
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.